Left sleeve lobectomy versus left pneumonectomy for the management of patients with non‐small cell lung cancer

The study was conducted to compare the outcomes of sleeve lobectomy (SL) and pneumonectomy (PN) for management of the left lung in patients with non‐small cell lung cancer (NSCLC).

[1]  R. Osarogiagbon,et al.  Evolution in the Surgical Care of Patients With Non-Small Cell Lung Cancer in the Mid-South Quality of Surgical Resection Cohort. , 2017, Seminars in thoracic and cardiovascular surgery.

[2]  P. Pagès,et al.  Sleeve lobectomy may provide better outcomes than pneumonectomy for non–small cell lung cancer. A decade in a nationwide study , 2017, The Journal of thoracic and cardiovascular surgery.

[3]  G. LehmanA Sleeve lobectomy or pneumonectomy : optimal management strategy using decision analysis techniques , 2017 .

[4]  B. Shi,et al.  For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy? , 2016, Journal of thoracic disease.

[5]  T. Nagayasu,et al.  The evolution of bronchoplasty and broncho-angioplasty as treatments for lung cancer: evaluation of 30 years of data from a single institution. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  N. Viñolas,et al.  SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015 , 2015, Clinical and Translational Oncology.

[7]  I. Ilonen,et al.  Bronchial sleeve resection or pneumonectomy for non-small cell lung cancer: a propensity-matched analysis of long-term results, survival and quality of life. , 2015, Journal of thoracic disease.

[8]  P. Pagès,et al.  Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study , 2015, European Respiratory Journal.

[9]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[10]  Jun Fan,et al.  Left lower sleeve lobectomy and systematic lymph node dissection by complete video-assisted thoracic surgery. , 2014, Journal of thoracic disease.

[11]  Jeremy J. W. Chen,et al.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer. , 2014, World journal of clinical oncology.

[12]  E. Rendina,et al.  Is sleeve lobectomy comparable in terms of short- and long-term results with pneumonectomy after induction therapy? A multicenter analysis. , 2014, The Annals of thoracic surgery.

[13]  M. Jiménez,et al.  Extended sleeve lobectomy: one more step toward avoiding pneumonectomy in centrally located lung cancer. , 2013, The Annals of thoracic surgery.

[14]  E. Felip,et al.  SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013 , 2013, Clinical and Translational Oncology.

[15]  F. Venuta,et al.  Sleeve Lobectomy Compared with Pneumonectomy after Induction Therapy for Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  Haoliang Sun,et al.  Sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a meta-analysis , 2012, World Journal of Surgical Oncology.

[17]  T. Habuchi,et al.  Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer , 2012, World Journal of Surgical Oncology.

[18]  J. Sonett,et al.  The surgical management of stage I and stage II lung cancer. , 2011, Surgical oncology clinics of North America.

[19]  Y. Shim,et al.  Sleeve Lobectomy as an Alternative Procedure to Pneumonectomy for Non-small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  H. Uramoto,et al.  Sleeve lobectomy for patients with non-small cell lung cancer. , 2010, International journal of surgery.

[21]  M. Olschewski,et al.  Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma. , 2005, The Annals of thoracic surgery.

[22]  W. Nishio,et al.  Survival of Resected Non-small Cell Lung Cancer Patients According to Pathological Stage , 2002 .

[23]  A. Bernard,et al.  Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. , 2001, The Journal of thoracic and cardiovascular surgery.

[24]  S. Fell A history of pneumonectomy. , 1999, Chest surgery clinics of North America.

[25]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.